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BioSense
Public Health Surveillance Through Collaboration
BioSense 2.0 is the only 
public health tool that 
provides a picture o f 
what is happening right 
now with any health 
condition, anywhere 
and everywhere in 
the country.
W hat Is BioSense?
The BioSense program tracks health problems 
in the United States as they evolve. It provides 
public health officials w ith the data, information, 
and tools needed to better prepare for and coordinate 
responses to safeguard and improve the health of Americans.
BioSense 2.0
The latest version, BioSense 2.0, launched in November 2011 and makes several 
changes to improve BioSense's ability to protect the health of the U.S. population. This 
collaborative data exchange system allows users to track health issues as they evolve.
BioSense 2.0 is the only public health tool that provides a picture of what is happening 
right now w ith any health condition, anywhere and everywhere in the country. 
BioSense 2.0 pulls together information on emergency department visits and 
hospitalizations from multiple sources, including the Department of Veterans Affairs 
(VA), the Department of Defense (DoD), and civilian hospitals from around the country. 
The BioSense program works w ith state or local health departments that have agreed 
to share data from their own emergency department m onitoring systems to collect 
data from civilian hospitals.
Analysis of these data provides insight into the health of communities and the country. 
Such data are vital to  guide decision making and actions by public health agencies at 
local, regional, and national levels.
BioSense 2.0 was developed and is governed by an active collaboration of CDC, state 
and local health departments, and other public health partners.
The BioSense program is administered by the Division of Notifiable Diseases and 
Healthcare Information in CDC's Public Health Surveillance and Informatics Program 
Office; Office of Surveillance, Epidemiology, and Laboratory Services.
Unique Features o f BioSense 2.0
Providing Data in a Distributed Cloud Environment
• BioSense 2.0 is the first Department of Health and Human Services system to 
move completely to  a distributed cloud computing environment. This distributed 
environment, governed jo in tly  by state, local, and federal representatives, 
provides local and state stakeholders secure data storage space and analytics 
tools at no cost to them. Most importantly, it provides a collaborative shared 
environment to advance public health surveillance practice and activities.
Sharing Data Across Jurisdictional Lines
• BioSense 2.0 is the only public health surveillance system that allows state and 
local health departments and CDC to quickly share information w ith each other 
across city, county, or state borders. When jo in ing BioSense, state and local health 
departments sign a data use agreement (DUA). The DUA allows them, along w ith 
CDC, to share data to conduct enhanced surveillance in emergencies and for 
events such as the presidential inauguration; the Super Bowl; or any other local, 
regional, or national event or emergency.
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Unique Features of BioSense 2.0 (cont.)
Helping State and Local Health Departments Meet 
Meaningful Use Requirements
• BioSense 2.0 expands the capacity o f state and local health 
departments to  support the electronic health records 
meaningful use programs by providing a catcher's m itt 
for syndromic surveillance data. Syndromic surveillance 
is a system for collecting and analyzing medical data to 
detect and m onitor disease outbreaks and harmful effects 
o f exposures to hazardous conditions. This feature gives 
state and local health departments access to  tim ely data 
so they can implement public health interventions in their 
communities and across jurisdictional boundaries.
BioSense Data Enhance Situation  
Awareness
2011 U.S. Heat Wave
• Data collected by BioSense between May and August 2011 
were used to monitor levels of heat-related illness during this 
period. Data were shared with state health departments in parts 
of the country most affected by the heat wave so they could 
implement preventative and responsive protocols.
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2009-2010 H1N1 Flu Pandemic
• From the beginning of the H1N1 pandemic in April 2009, 
BioSense provided vital information from emergency 
departments, laboratories, and pharmacies to the CDC 
Emergency Operations Center, CDC's Influenza Division, and 
state and local public health departments to help them make 
decisions about immunization recommendations, school and 
public building closures, and other response steps.
• As demonstrated in the H1N1 pandemic, BioSense is currently 
the only source of data that can assess the severity of illness in 
emergency rooms.
2010 Deepwater Horizon Gulf Oil Spill
• The BioSense program worked with state and local jurisdictions 
in Alabama, Florida, Louisiana, Mississippi, and Texas; the 
Department of Veterans Affairs; and the Department of Defense 
to monitor 21 specific syndromes to identify potential disease 
outbreaks or harmful effects of exposure to oil or chemicals used 
for cleanup and to monitor several mental health conditions 
from 86 coastal healthcare facilities. BioSense produced daily 
situation awareness reports for state and local responders in 
affected areas, which allowed responders to assure Gulf Coast 
residents that the immediate negative health effect from the oil 
spill was limited.
2011 Japanese Tsunami and Nuclear Disaster in Fukushima
• After the Fukushima Daiichi nuclear disaster following the 
2011 Japanese earthquake and tsunami, the BioSense program 
monitored healthcare activity for potential harmful effects of 
exposure to radiation in 20 DoD facilities in Japan. BioSense used 
cluster detection methods to identify syndromes associated with 
injuries and possible radiation exposure as well as search for 
specific ICD-9-CM codes associated with radiation exposure. The 
data demonstrated that American troops and family members 
showed no increase in radiation sickness or injuries during and 
after this event.
2012 Dengue Detection Project in Florida and Hawaii
• Data from BioSense were used to enhance surveillance for 
dengue by identifying people presenting with dengue-like 
symptoms (including fever and rash) at VA facilities and referring 
likely cases of dengue for further investigation by local health 
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